Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

Related Citations for PubMed (Select 23434895)

1.

Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia.

Schuetz P, Litke A, Albrich WC, Mueller B.

Curr Opin Infect Dis. 2013 Apr;26(2):159-67. doi: 10.1097/QCO.0b013e32835d0bec. Review.

PMID:
23434895
2.

Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.

Bello S, Lasierra AB, Mincholé E, Fandos S, Ruiz MA, Vera E, de Pablo F, Ferrer M, Menendez R, Torres A.

Eur Respir J. 2012 May;39(5):1144-55. doi: 10.1183/09031936.00080411. Epub 2011 Nov 10.

3.

Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.

Huang DT, Angus DC, Kellum JA, Pugh NA, Weissfeld LA, Struck J, Delude RL, Rosengart MR, Yealy DM.

Chest. 2009 Sep;136(3):823-31. doi: 10.1378/chest.08-1981. Epub 2009 Apr 10.

4.

Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.

Courtais C, Kuster N, Dupuy AM, Folschveiller M, Jreige R, Bargnoux AS, Guiot J, Lefebvre S, Cristol JP, Sebbane M.

Am J Emerg Med. 2013 Jan;31(1):215-21. doi: 10.1016/j.ajem.2012.07.017. Epub 2012 Sep 20.

PMID:
23000327
5.

Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.

Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.

Am J Respir Crit Care Med. 2010 Dec 1;182(11):1426-34. doi: 10.1164/rccm.201003-0415OC. Epub 2010 Jul 16.

PMID:
20639437
6.

Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.

Renaud B, Schuetz P, Claessens YE, Labarère J, Albrich W, Mueller B.

Chest. 2012 Dec;142(6):1447-54.

PMID:
22661450
7.

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].

Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B.

Crit Care. 2006;10(3):R96. Epub 2006 Jun 28.

8.

Biomarkers and community-acquired pneumonia: tailoring management with biological data.

Torres A, Ramirez P, Montull B, Menéndez R.

Semin Respir Crit Care Med. 2012 Jun;33(3):266-71. doi: 10.1055/s-0032-1315638. Epub 2012 Jun 20. Review.

PMID:
22718212
9.

Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.

Lindstrom ST, Wong EK.

Intern Med J. 2014 Apr;44(4):390-7. doi: 10.1111/imj.12374.

PMID:
24528892
10.

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.

Suberviola B, Castellanos-Ortega A, Llorca J, Ortiz F, Iglesias D, Prieto B.

Swiss Med Wkly. 2012 Mar 19;142:w13542. doi: 10.4414/smw.2012.13542.

11.

Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.

Drozdov D, Thomer A, Meili M, Schwarz S, Kouegbe RB, Regez K, Guglielmetti M, Schild U, Conca A, Schäfer P, Reutlinger B, Ottiger C, Buchkremer F, Litke A, Schuetz P, Huber A, Bürgi U, Fux CA, Bock A, Müller B, Albrich WC; Triple P study group.

Trials. 2013 Mar 22;14:84. doi: 10.1186/1745-6215-14-84.

12.

Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care?

Schuetz P, Haubitz S, Mueller B.

Curr Opin Crit Care. 2012 Aug;18(4):341-9. doi: 10.1097/MCC.0b013e328354b2c8. Review.

PMID:
22610364
13.

Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.

Bloos F, Marshall JC, Dellinger RP, Vincent JL, Gutierrez G, Rivers E, Balk RA, Laterre PF, Angus DC, Reinhart K, Brunkhorst FM.

Crit Care. 2011;15(2):R88. doi: 10.1186/cc10087. Epub 2011 Mar 7.

14.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD007498. doi: 10.1002/14651858.CD007498.pub2. Review.

PMID:
22972110
15.

Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.

Long W, Deng X, Zhang Y, Lu G, Xie J, Tang J.

Respirology. 2011 Jul;16(5):819-24. doi: 10.1111/j.1440-1843.2011.01978.x.

PMID:
21507143
16.

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.

Albrich WC, Dusemund F, Rüegger K, Christ-Crain M, Zimmerli W, Bregenzer T, Irani S, Buergi U, Reutlinger B, Mueller B, Schuetz P.

BMC Infect Dis. 2011 May 3;11:112. doi: 10.1186/1471-2334-11-112.

17.

Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.

Claessens YE, Mathevon T, Kierzek G, Grabar S, Jegou D, Batard E, Loyer C, Davido A, Hausfater P, Robert H, Lavagna-Perez L, Bernot B, Plaisance P, Leroy C, Renaud B.

Intensive Care Med. 2010 May;36(5):799-809. doi: 10.1007/s00134-010-1818-4. Epub 2010 Mar 16.

PMID:
20232049
18.

Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.

Travaglino F, De Berardinis B, Magrini L, Bongiovanni C, Candelli M, Silveri NG, Legramante J, Galante A, Salerno G, Cardelli P, Di Somma S.

BMC Infect Dis. 2012 Aug 8;12:184.

19.

Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.

Ramírez P, Ferrer M, Martí V, Reyes S, Martínez R, Menéndez R, Ewig S, Torres A.

Crit Care Med. 2011 Oct;39(10):2211-7. doi: 10.1097/CCM.0b013e3182257445.

PMID:
21705887
20.

Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study.

Schuetz P, Friedli N, Grolimund E, Kutz A, Haubitz S, Christ-Crain M, Thomann R, Zimmerli W, Hoess C, Henzen C, Mueller B; ProHOSP Study Group.

Diabetologia. 2014 Feb;57(2):275-84. doi: 10.1007/s00125-013-3112-9. Epub 2013 Nov 24.

PMID:
24270903
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk